Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Health, what discussions he has had about extending the remit of the Cancer Drugs Fund to include access to other cancer treatments such as advanced stereotactic radiotherapy.

George Freeman

We announced a £160 million boost to the Cancer Drugs Fund at the end of August 2014.

NHS England announced on 12 January 2015 that it plans to increase the level of investment for drugs in the Cancer Drugs Fund from £280 million in 2014-15 to an expected £340 million in 2015-16.

NHS England has also announced the extension of its Commissioning through the Evaluation programme to include stereotactic ablative radiotherapy (SABR). This will enable the number of cancer patients eligible to access SABR treatment to rise significantly, by 750 new patients a year and widen the number of cancers being treated.